Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor – QINLOCK Significantly Reduced the Risk of Disease Progression or Death by 85% and Showed Clinically Meaningful Overall Survival in the...
Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer – ARV-471 continues to show a favorable tolerability profile and robust ER...
Kit Check and Fagron Partner to Launch RFID-tagged 503B Products in February 2022 503B Compounder Set to Manufacture Products Embedded with RFID tags Compatible with Kit Check Scanning Technology ARLINGTON, Va., Dec. 8, 2021 /PRNewswire/ — Kit Check, the market leader...
CLEERLY NAMED TO THE 2021 CB INSIGHTS DIGITAL HEALTH 150List of Most Innovative Digital Health Startups NEW YORK, December 8, 2021 — CB Insights today named Cleerly to its third annual Digital Health 150, which showcases the 150 most promising private digital...
Ochsner Health Makes Finding the Right Provider Easier with Solutions from Kyruus Louisiana’s Largest Healthcare Provider Has Implemented a New Provider Directory and Enhanced Search Capabilities to Simplify Patient Access Boston, MA – December 7, 2021– Kyruus, the...
Neurana Pharmaceuticals Completes Patient Enrollment in Phase 3 RESUME-1 StudySAN DIEGO, Calif., November 29, 2021 — Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced it has completed...
Recent Comments